John Huang

Halolife Group was established in 2012， encompasses several subsidiaries.

Have efficient and experienced R&D and production team, supported by cGMP quality system.

Products cover chemical small-molecule drug API and formulations, peptides, small nucleic acid , and biologic drugs (including monoclonal antibodies, bispecific antibodies, and ADC drugs).

Markets covering China, the United States, Europe, the Middle East, Africa, and other countries or regions along the “Belt and Road” initiative.

Provide a full industry chain product supply, from key intermediates to active pharmaceutical ingredients (APIs) and formulations, as well as comprehensive support services covering factory construction, technology transfer, and product sales.